144 related articles for article (PubMed ID: 7761578)
1. The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury.
Hanson WR; Zhen W; Geng L; Hunter N; Milas L
Radiat Res; 1995 Jun; 142(3):281-7. PubMed ID: 7761578
[TBL] [Abstract][Full Text] [Related]
2. Increase in radioresponse of murine tumors by treatment with indomethacin.
Furuta Y; Hunter N; Barkley T; Hall E; Milas L
Cancer Res; 1988 Jun; 48(11):3008-13. PubMed ID: 3365690
[TBL] [Abstract][Full Text] [Related]
3. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
[TBL] [Abstract][Full Text] [Related]
4. Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.
Grégoire V; Hunter NR; Brock WA; Hittelman WN; Plunkett W; Milas L
Radiat Res; 1996 Nov; 146(5):548-53. PubMed ID: 8896581
[TBL] [Abstract][Full Text] [Related]
5. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L
Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694
[TBL] [Abstract][Full Text] [Related]
6. Tumors arising in SCID mice share enhanced radiation sensitivity of SCID normal tissues.
Budach W; Hartford A; Gioioso D; Freeman J; Taghian A; Suit HD
Cancer Res; 1992 Nov; 52(22):6292-6. PubMed ID: 1423275
[TBL] [Abstract][Full Text] [Related]
7. Misoprostol-induced radioprotection of Syrian hamster embryo cells in utero from cell death and oncogenic transformation.
Miller RC; LaNasa P; Hanson WR
Radiat Res; 1994 Jul; 139(1):109-14. PubMed ID: 8016299
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis.
Vuyyuri SB; Hamstra DA; Khanna D; Hamilton CA; Markwart SM; Campbell KC; Sunkara P; Ross BD; Rehemtulla A
Clin Cancer Res; 2008 Apr; 14(7):2161-70. PubMed ID: 18381958
[TBL] [Abstract][Full Text] [Related]
9. Toxicity, radiation sensitivity modification, and combined drug effects of ascorbic acid with misonidazole in vivo on FSaII murine fibrosarcomas.
Okunieff P; Suit HD
J Natl Cancer Inst; 1987 Aug; 79(2):377-81. PubMed ID: 3474467
[TBL] [Abstract][Full Text] [Related]
10. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol, a PGE1 analog, protects mice from fission-neutron injury.
Hanson WR; Grdina DJ
Radiat Res; 1991 Oct; 128(1 Suppl):S12-7. PubMed ID: 1656482
[TBL] [Abstract][Full Text] [Related]
12. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
13. Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721.
Besa PC; Hunter NR; Milas L
Radiat Res; 1993 Jul; 135(1):93-7. PubMed ID: 8392213
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin.
Furuta Y; Hall ER; Sanduja S; Barkley T; Milas L
Cancer Res; 1988 Jun; 48(11):3002-7. PubMed ID: 3130182
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E1 and misoprostol increase epidermal growth factor production in 3D-cultured human annulus cells.
Gruber HE; Hoelscher G; Loeffler B; Chow Y; Ingram JA; Halligan W; Hanley EN
Spine J; 2009 Sep; 9(9):760-6. PubMed ID: 19535298
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
[TBL] [Abstract][Full Text] [Related]
17. Tumor growth and tumor radiosensitivity in mice given myeloprotective doses of fibroblast growth factors.
Ding I; Huang K; Snyder ML; Cook J; Zhang L; Wersto N; Okunieff P
J Natl Cancer Inst; 1996 Oct; 88(19):1399-404. PubMed ID: 8827018
[TBL] [Abstract][Full Text] [Related]
18. Intravenous basic fibroblast growth factor protects the lung but not mediastinal organs against radiation-induced apoptosis in vivo.
Fuks Z; Alfieri A; Haimovitz-Friedman A; Seddon A; Cordon-Cardo C
Cancer J Sci Am; 1995; 1(1):62-72. PubMed ID: 9166456
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Milas L; Hunter N; Reid BO; Thames HD
Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Li C; Price JE; Milas L; Hunter NR; Ke S; Yu DF; Charnsangavej C; Wallace S
Clin Cancer Res; 1999 Apr; 5(4):891-7. PubMed ID: 10213226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
